PubMed=7251319
Isaacs J.T., Yu G.W., Coffey D.S.
The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
Invest. Urol. 19:20-23(1981)

PubMed=3774632; DOI=10.1002/pros.2990090306
Isaacs J.T., Isaacs W.B., Feitz W.F.J., Scheres J.
Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.
Prostate 9:261-281(1986)

PubMed=3174494; DOI=10.1002/pros.2990130208
Isaacs J.T., Hukku B.
Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer.
Prostate 13:165-188(1988)

PubMed=7910810; DOI=10.1002/ijc.2910570519
Bashir I., Sikora K., Abel P., Foster C.S.
Establishment and in vivo characterization of multidrug-resistant Dunning R3327 rat prostate-carcinoma cell-lines.
Int. J. Cancer 57:719-726(1994)

PubMed=8687134
Pandalai P.K., Pilat M.J., Yamazaki K., Naik H., Pienta K.J.
The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
Anticancer Res. 16:815-820(1996)

PubMed=23467722; DOI=10.3892/or.2013.2323
Musialik E., Ryszawy D., Madeja Z., Korohoda W.
Morpho-physiological heterogeneity of cells within two rat prostate carcinoma cell lines AT-2 and MAT-LyLu differing in the degree of malignancy observed by cell cloning and the effects of caffeine, theophylline and papaverine upon a proportion of the clones.
Oncol. Rep. 29:1789-1796(2013)